Jeannette Lee, Gerald Andriole, Andrew Avins, E David Crawford, Harris Foster, Steven Kaplan, Karl Kreder, John Kusek, Andrew McCullough, Kevin McVary, Sreelatha Meleth, Michael Naslund, J Curtis Nickel, Leroy Nyberg, Claus Roehrborn, O Dale Williams, Michael Barry
BACKGROUND: Benign prostatic hyperplasia (BPH), a common condition among older men, confers its morbidity through potentially bothersome lower urinary tract symptoms. Treatments for BPH include drugs such as alpha-adrenergic receptor blockers and 5-alpha reductase inhibitors, minimally invasive therapies that use heat to damage or destroy prostate tissue, and surgery including transurethral resection of the prostate. Complementary and alternative medicines are gaining popularity in the US...
December 2009: Clinical Trials: Journal of the Society for Clinical Trials